NextCure Inc reports results for the quarter ended in March - Earnings Summary

NextCure

06/05/2022 22:26

* NextCure Inc  NXTC.OQ  reported a quarterly adjusted loss
of 74
cents​​ per share for the quarter ended in March. The mean
expectation of six analysts for the quarter was for a loss of 67
cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * NextCure Inc's reported EPS for the quarter was a loss
of 74
cents​.
    * The mean earnings estimate of analysts had risen by
about 1.7%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * NextCure Inc shares had fallen by 20.2% this quarter and
lost 35.3% so far this year.
    * The company reported a quarterly loss of $20.6 million.
    * Wall Street's median 12-month price target for NextCure
Inc is
$16.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated May 6 at 09:26 p.m.  ​All
figures in US dollars unless otherwise stated